The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
OX40, OX40L and Autoimmunity: a Comprehensive Review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ito, T., Wang, Y.-H., Duramad, O., Hori, T., Delespesse, G. J., Watanabe, N., Qin, F. X.-F., Yao, Z., Cao, W., & Liu, Y.-J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051135 · Cited by 1,129
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Han, J.-W., Zheng, H.-F., Cui, Y., Sun, L.-D., Ye, D.-Q., Hu, Z., Xu, J.-H., Cai, Z.-M., Huang, W., Zhao, G.-P., et al. (2009) · Nature Genetics · doi:10.1038/ng.472 · Cited by 936
The role of TNF superfamily members in T-cell function and diseases
Croft, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2526 · Cited by 920
The epidemiology of autoimmune diseases
Cooper, G. S., & Stroehla, B. C. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00006-5 · Cited by 880
Gateva, V., Sandling, J. K., Hom, G., Taylor, K. E., Chung, S. A., Sun, X., Ortmann, W., Kosoy, R., Ferreira, R. C., Nordmark, G., et al. (2009) · Nature Genetics · doi:10.1038/ng.468 · Cited by 810
OX40 Promotes Bcl-xL and Bcl-2 Expression and Is Essential for Long-Term Survival of CD4 T Cells
Rogers, P. R., Song, J., Gramaglia, I., Killeen, N., & Croft, M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00191-1 · Cited by 646
The significance of OX40 and OX40L to T‐cell biology and immune disease
Croft, M., So, T., Duan, W., & Soroosh, P. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00766.x · Cited by 604
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Croft, M. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101243 · Cited by 548
Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses
Gramaglia, I., Weinberg, A. D., Lemon, M., & Croft, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6510 · Cited by 527
Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S., & Iwakura, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035999100 · Cited by 490
PATERSON, D., JEFFERIES, W., GREEN, J., BRANDON, M., CORTHESY, P., PUKLAVEC, M., & WILLIAMS, A. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90122-2 · Cited by 447
OX40 costimulation turns off Foxp3+ Tregs
Vu, M. D., Xiao, X., Gao, W., Degauque, N., Chen, M., Kroemer, A., Killeen, N., Ishii, N., & Chang Li, X. (2007) · Blood · doi:10.1182/blood-2007-01-070748 · Cited by 428
Expression and function of OX40 ligand on human dendritic cells
Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., & Delespesse, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3838 · Cited by 420
Nakae, S., Suto, H., Iikura, M., Kakurai, M., Sedgwick, J. D., Tsai, M., & Galli, S. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2238 · Cited by 412
Gramaglia, I., Jember, A., Pippig, S. D., Weinberg, A. D., Killeen, N., & Croft, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3043 · Cited by 409
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
Piconese, S., Valzasina, B., & Colombo, M. P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071341 · Cited by 405
Stüber, E., Neurath, M., Calderhead, D., Perry Fell, H., & Strober, W. (1995) · Immunity · doi:10.1016/1074-7613(95)90031-4 · Cited by 390
Mallett, S., Fossum, S., & Barclay, A. N. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08211.x · Cited by 379
Kopf, M., Ruedl, C., Schmitz, N., Gallimore, A., Lefrang, K., Ecabert, B., Odermatt, B., & Bachmann, M. F. (1999) · Immunity · doi:10.1016/s1074-7613(00)80144-2 · Cited by 321
Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S., & Uchiyama, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2185 · Cited by 309
Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells
Takeda, I., Ine, S., Killeen, N., Ndhlovu, L. C., Murata, K., Satomi, S., Sugamura, K., & Ishii, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3580 · Cited by 308
Stüber, E., & Strober, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.979 · Cited by 286
Mahmud, S. A., Manlove, L. S., Schmitz, H. M., Xing, Y., Wang, Y., Owen, D. L., Schenkel, J. M., Boomer, J. S., Green, J. M., Yagita, H., et al. (2014) · Nature Immunology · doi:10.1038/ni.2849 · Cited by 281
Walker, L. S. K., Gulbranson-Judge, A., Flynn, S., Brocker, T., Raykundalia, C., Goodall, M., Förster, R., Lipp, M., & Lane, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1115 · Cited by 276
Self-citationGodfrey, W. R., Fagnoni, F. F., Harara, M. A., Buck, D., & Engleman, E. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.757 · Cited by 271
Ohshima, Y., Yang, L.-P., Uchiyama, T., Tanaka, Y., Baum, P., Sergerie, M., Hermann, P., & Delespesse, G. (1998) · Blood · doi:10.1182/blood.v92.9.3338 · Cited by 268
Weinberg, A. D., Wegmann, K. W., Funatake, C., & Whitham, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1818 · Cited by 252
Definition of human autoimmunity — autoantibodies versus autoimmune disease
Lleo, A., Invernizzi, P., Gao, B., Podda, M., & Gershwin, M. E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.12.002 · Cited by 250
ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy
Faraco, J., Lin, L., Kornum, B. R., Kenny, E. E., Trynka, G., Einen, M., Rico, T. J., Lichtner, P., Dauvilliers, Y., Arnulf, I., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003270 · Cited by 245
Linton, P.-J., Bautista, B., Biederman, E., Bradley, E. S., Harbertson, J., Kondrack, R. M., Padrick, R. C., & Bradley, L. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021290 · Cited by 242
OX40 signaling favors the induction of TH9 cells and airway inflammation
Xiao, X., Balasubramanian, S., Liu, W., Chu, X., Wang, H., Taparowsky, E. J., Fu, Y.-X., Choi, Y., Walsh, M. C., & Li, X. C. (2012) · Nature Immunology · doi:10.1038/ni.2390 · Cited by 237
Signaling through OX40 (CD134) breaks peripheral T-cell tolerance
Bansal-Pakala, P., Gebre-Hiwot Jember, A., & Croft, M. (2001) · Nature Medicine · doi:10.1038/90942 · Cited by 230
Shaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M., Cheroutre, H., & Ware, C. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6330 · Cited by 230
Souza, H. S., Elia, C. C. S., Spencer, J., & MacDonald, T. T. (1999) · Gut · doi:10.1136/gut.45.6.856 · Cited by 224
Graham, D. S. C., Graham, R. R., Manku, H., Wong, A. K., Whittaker, J. C., Gaffney, P. M., Moser, K. L., Rioux, J. D., Altshuler, D., Behrens, T. W., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.47 · Cited by 222
Maxwell, J. R., Weinberg, A., Prell, R. A., & Vella, A. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.107 · Cited by 219
Piconese, S., Gri, G., Tripodo, C., Musio, S., Gorzanelli, A., Frossi, B., Pedotti, R., Pucillo, C. E., & Colombo, M. P. (2009) · Blood · doi:10.1182/blood-2009-05-220004 · Cited by 211
So, T., & Croft, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1427 · Cited by 210
Malmström, V., Shipton, D., Singh, B., Al-Shamkhani, A., Puklavec, M. J., Barclay, A. N., & Powrie, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6972 · Cited by 209
T-cell costimulation–biology, therapeutic potential, and challenges.
Sharpe, A. H., & Abbas, A. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068087 · Cited by 206
Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.
Calderhead, D. M., Buhlmann, J. E., van den Eertwegh, A. J. M., Claassen, E., Noelle, R. J., & Fell, H. P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5261 · Cited by 202
Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A., & Uchiyama, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5808 · Cited by 200
OX40 ligand shuts down IL-10-producing regulatory T cells
Ito, T., Wang, Y.-H., Duramad, O., Hanabuchi, S., Perng, O. A., Gilliet, M., Qin, F. X.-F., & Liu, Y.-J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603107103 · Cited by 198
Vogel, K. U., Edelmann, S. L., Jeltsch, K. M., Bertossi, A., Heger, K., Heinz, G. A., Zöller, J., Warth, S. C., Hoefig, K. P., Lohs, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.004 · Cited by 194
Brocker, T., Gulbranson‐Judge, A., Flynn, S., Riedinger, M., Raykundalia, C., & Lane, P. J. L. (1999) · European Journal of Immunology · Cited by 188
Self-citationAgonist Antibodies to TNFR Molecules That Costimulate T and NK Cells
Melero, I., Hirschhorn-Cymerman, D., Morales-Kastresana, A., Sanmamed, M. F., & Wolchok, J. D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2065 · Cited by 176
Costimulation of CD8 T Cell Responses by OX40
Bansal-Pakala, P., Halteman, B. S., Cheng, M. H.-Y., & Croft, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4821 · Cited by 175
Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood
Byun, M., Ma, C. S., Akçay, A., Pedergnana, V., Palendira, U., Myoung, J., Avery, D. T., Liu, Y., Abhyankar, A., Lorenzo, L., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130592 · Cited by 167
Cutting Edge: OX40 Agonists Can Drive Regulatory T Cell Expansion if the Cytokine Milieu Is Right
Ruby, C. E., Yates, M. A., Hirschhorn-Cymerman, D., Chlebeck, P., Wolchok, J. D., Houghton, A. N., Offner, H., & Weinberg, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901112 · Cited by 164
Kashiwakura, J.-I., Yokoi, H., Saito, H., & Okayama, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5247 · Cited by 164
Robust B Cell Immunity but Impaired T Cell Proliferation in the Absence of CD134 (OX40)
Pippig, S. D., Peña-Rossi, C., Long, J., Godfrey, W. R., Fowell, D. J., Reiner, S. L., Birkeland, M. L., Locksley, R. M., Barclay, A. N., & Killeen, N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6520 · Cited by 163
The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
Moran, A. E., Kovacsovics-Bankowski, M., & Weinberg, A. D. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.01.004 · Cited by 162
Science gone translational: the OX40 agonist story
Weinberg, A. D., Morris, N. P., Kovacsovics-Bankowski, M., Urba, W. J., & Curti, B. D. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01069.x · Cited by 161
OX40 is required for regulatory T cell–mediated control of colitis
Griseri, T., Asquith, M., Thompson, C., & Powrie, F. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091618 · Cited by 160
Immune regulation and control of regulatory T cells by OX40 and 4-1BB
So, T., Lee, S., & Croft, M. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.003 · Cited by 156
Weinberg, A. D., BOURDETTE, D. N., Sullivan, T. J., Lemon, M., Wallin, J. J., Maziarz, R. T., Davey, M. P., Palida, F., Godfrey, W. R., Engleman, E. G., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-183 · Cited by 156
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
Gourh, P., Arnett, F. C., Tan, F. K., Assassi, S., Divecha, D., Paz, G., McNearney, T. A., Draeger, H. T., Reveille, J. D., Mayes, M. D., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.116434 · Cited by 145
So, T., & Croft, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00139 · Cited by 144
Jenkins, S. J., Perona‐Wright, G., Worsley, A. G. F., Ishii, N., & MacDonald, A. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3515 · Cited by 142
Dannull, J., Nair, S. K., Su, Z. Z., Boczkowski, D., DeBeck, C., Yang, B. K., Gilboa, E., & Vieweg, J. (2004) · Blood · doi:10.1182/blood-2004-10-3944 · Cited by 133
Constitutive OX40/OX40 Ligand Interaction Induces Autoimmune-Like Diseases
Murata, K., Nose, M., Ndhlovu, L. C., Sato, T., Sugamura, K., & Ishii, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4628 · Cited by 130
Critical, but Conditional, Role of OX40 in Memory T Cell-Mediated Rejection
Vu, M. D., Clarkson, M. R., Yagita∥, H., Turka, L. A., Sayegh, M. H., & Li, X. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1394 · Cited by 123
OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice
Zaini, J., Andarini, S., Tahara, M., Saijo, Y., Ishii, N., Kawakami, K., Taniguchi, M., Sugamura, K., Nukiwa, T., & Kikuchi, T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32693 · Cited by 123
Jourdan, P., Vendrell, J.-P., Huguet, M., Segondy, M., Bousquet, J. J., Pène, J., & Yssel, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.716 · Cited by 120
Krause, P., Bruckner, M., Uermösi, C., Singer, E., Groettrup, M., & Legler, D. F. (2008) · Blood · doi:10.1182/blood-2008-05-157123 · Cited by 117
Nohara, C., Akiba, H., Nakajima, A., Inoue, A., Koh, C., Ohshima, H., Yagita∥, H., Mizuno, Y., & Okumura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2108 · Cited by 116
OX 40L blockade and allergen‐induced airway responses in subjects with mild asthma
Gauvreau, G. M., Boulet, L. ‐., Cockcroft, D. W., FitzGerald, J. M., Mayers, I., Carlsten, C., Laviolette, M., Killian, K. J., Davis, B. E., Larché, M., et al. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12235 · Cited by 114
Aten, J., Roos, A., Claessen, N., Schilder-Tol, E. J. M., ten Berge, I. J. M., & Weening, J. J. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1181426 · Cited by 114
Ndhlovu, L. C., Ishii, N., Murata, K., Sato, T., & Sugamura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2991 · Cited by 109
OX40-OX40 Ligand Interaction through T Cell-T Cell Contact Contributes to CD4 T Cell Longevity
Soroosh, P., Ine, S., Sugamura, K., & Ishii, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5975 · Cited by 106
IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 Pathway
Maxwell, J. R., Yadav, R., Rossi, R. J., Ruby, C. E., Weinberg, A. D., Aguila, H. L., & Vella, A. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.234 · Cited by 104
New Insights on OX40 in the Control of T Cell Immunity and Immune Tolerance In Vivo
Xiao, X., Gong, W., Demirci, G., Liu, W., Spoerl, S., Chu, X., Bishop, D. K., Turka, L. A., & Li, X. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101373 · Cited by 102
Voo, K. S., Bover, L. C., Harline, M. L., Vien, L., Facchinetti, V., Arima, K., Kwak, L. W., & Liu, Y. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202752 · Cited by 99
T cell-activation in neuromyelitis optica lesions plays a role in their formation
Hastermann, M., Kawakami, N., Kitic, M., Bauer, J., Martins, R., Fischer, M.-T., Machado-Santos, J., Mader, S., Ellwart, J. W., Misu, T., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-85 · Cited by 94
Increased Serum Soluble OX40 in Patients with Systemic Sclerosis
Komura, K., Yoshizaki, A., Kodera, M., Iwata, Y., Ogawa, F., Shimizu, K., Wayaku, T., Yukami, T., MURATA, M., Hasegawa, M., et al. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080120 · Cited by 92
Imura, A., Hori, T., Imada, K., Kawamata, S., Tanaka, Y., Imamura, S., & Uchiyama, T. (1997) · Blood · doi:10.1182/blood.v89.8.2951 · Cited by 88
Sánchez, E., Webb, R. D., Rasmussen, A., Kelly, J. A., Riba, L., Kaufman, K. M., Torre, I. G.-D. L., Moctezuma, J. F., Maradiaga‐Ceceña, M. A., Cardiel‐Rios, M. H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27753 · Cited by 86
Saijo, S., Asano, M., Horai, R., Yamamoto, H., & Iwakura, Y. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10172 · Cited by 85
Functional expression of CD134 by neutrophils
Baumann, R., Yousefi, S., Simon, D., Russmann, S., Mueller, C., & Simon, H. (2004) · European Journal of Immunology · doi:10.1002/eji.200424863 · Cited by 83
Buchan, S. L., Manzo, T., Flutter, B. R., Rogel, A., Edwards, N., Zhang, L., Sivakumaran, S., Ghorashian, S., Carpenter, B., Bennett, C. L., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401644 · Cited by 81
Bossini‐Castillo, L., Broen, J. C. A., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Ortego‐Centeno, N., Espinosa, G., Carreira, P. E., Camps, M. T., Navarrete‐Navarrete, N., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141838 · Cited by 80
OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent
Prell, R. A., Evans, D. E., Thalhofer, C., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5997 · Cited by 79
Kim, M., Toellner, K., White, A. J., McConnell, F. M., Gaspal, F., Parnell, S. M., Jenkinson, E. J., Anderson, G., & Lane, P. J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3074 · Cited by 77
Self-citationCD28-independent induction of experimental autoimmune encephalomyelitis
Chitnis, T., Najafian, N., Abdallah, K. A., Dong, V. M., Yagita∥, H., Sayegh, M. H., & Khoury, S. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11220 · Cited by 76
OX40 Drives Protective Vaccinia Virus-Specific CD8 T Cells,
Salek‐Ardakani, S., Moutaftsi, M., Crotty, S., Sette, A., & Croft, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7969 · Cited by 76
Differential Requirements for OX40 Signals on Generation of Effector and Central Memory CD4+ T Cells
Soroosh, P., Ine, S., Sugamura, K., & Ishii, N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5014 · Cited by 69
Elyaman, W., Kivisäkk, P., Reddy, J., Chitnis, T., Raddassi, K., Imitola, J., Bradshaw, E., Kuchroo, V., Yagita, H., Sayegh, M., et al. (2008) · American Journal of Pathology · doi:10.2353/ajpath.2008.080142 · Cited by 67
Kaleeba, J. A. R. (1998) · International Immunology · doi:10.1093/intimm/10.4.453 · Cited by 67
Thymic OX40 Expression Discriminates Cells Undergoing Strong Responses to Selection Ligands
Klinger, M., Kim, J. K., Chmura, S. A., Barczak, A. J., Erle, D. J., & Killeen, N. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900010 · Cited by 65
Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
Börnsen, L. S., Christensen, J. R., Ratzer, R. L., Oturai, A. B., Sørensen, P. S., Søndergaard, H. B., & Sellebjerg, F. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047578 · Cited by 62
Morris, N. P., Peters, C., Montler, R. D., Hu, H., Curti, B. D., Urba, W. J., & Weinberg, A. D. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.004 · Cited by 61
OX40 Ligand Regulates Inflammation and Mortality in the Innate Immune Response to Sepsis
Karulf, M., Kelly, A., Weinberg, A. D., & Gold, J. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000404 · Cited by 61
Kotani, A., Hori, T., Matsumura, Y., & Uchiyama, T. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00082-2 · Cited by 60
Therapeutic effect of anti-OX40L and anti-TNF-α MAbs in a murine model of chronic colitis
Totsuka, T., Kanai∥, T., Uraushihara, K., Iiyama, R., YAMAZAKI, M., Akiba, H., Yagita∥, H., Okumura, K., & Watanabe, M. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00450.2002 · Cited by 60
Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice
Gaspal, F., Withers, D. R., Saini, M., Bekiaris, V., McConnell, F. M., White, A. J., Khan, M., Yagita∥, H., Walker, L. S. K., Anderson, G., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101484 · Cited by 59
Self-citationCharacteristics of Inflammatory Cells in Spontaneous Autoimmune Thyroiditis of NOD.H-2h4 Mice
Yu, S., Medling, B., Yagita∥, H., & Braley‐Mullen, H. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0458 · Cited by 58
Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus TNFSF4
Manku, H., Langefeld, C. D., Guerra, S. G., Malik, T. H., Alarcón-Riquelme, M. E., Anaya, J., Bae, S., Boackle, S. A., Brown, E. E., Criswell, L. A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003554 · Cited by 57
Activation of OX40 Augments Th17 Cytokine Expression and Antigen-Specific Uveitis
Zhang, Z., Zhong, W., Hinrichs, D. J., Wu, X., Weinberg, A. D., Hall, M., Spencer, D., Wegmann, K. W., & Rosenbaum, J. T. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100353 · Cited by 55
Stüber, Büschenfeld, Lüttges, Freier, V., Arendt, T., & Fölsch (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00658.x · Cited by 54
Sato, T., Ishii, N., Murata, K., Kikuchi, K., Nakagawa, S., Ndhlovu, L. C., & Sugamura, K. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3326::aid-immu3326>3.0.co;2-9 · Cited by 53
Coexpression of CD25 and OX40 (CD134) Receptors Delineates Autoreactive T-cells in Type 1 Diabetes
Endl, J., Rosinger, S., Schwarz, B., Friedrich, S. O., Rothe, G., Karges, W., Schlosser, M., EIERMANN, T. H., Schendel, D. J., & Boehm, B. O. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0387 · Cited by 52
Mestas, J., Crampton, S. P., Hori, T., & Hughes, C. C. W. (2005) · International Immunology · doi:10.1093/intimm/dxh255 · Cited by 52
Kurche, J. S., Haluszczak, C., McWilliams, J. A., Sanchez, P. J., & Kedl, R. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102550 · Cited by 51
Activated T cells express the OX40 ligand: requirements for induction and costimulatory function
Mendel, I., & Shevach, E. M. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02279.x · Cited by 48
Wilde, B., Dolff, S., Cai, X., Specker, C., Becker, J. U., Tötsch, M., Costabel, U., Dürig, J., Kribben, A., Tervaert, J.-W. C., et al. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn461 · Cited by 47
OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis
Findlay, E. G., Danks, L., Madden, J., Cavanagh, M., McNamee, K., McCann, F. E., Snelgrove, R. J., Shaw, S., Feldmann, M., Taylor, P. C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321071111 · Cited by 46
Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment
Bresson, D., Fousteri, G., Manenkova, Y., Croft, M., & von Herrath, M. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.10.001 · Cited by 41
Coustet, B., Bouaziz, M., Dieudé, P., Guedj, M., Bossini-Castillo, L., Agarwal, S., Radstake, T., Martín, J., Gourh, P., Elhai, M., et al. (2012) · Journal of Rheumatology · doi:10.3899/jrheum.111270 · Cited by 41
Paradoxical Dampening of Anti-Islet Self-Reactivity but Promotion of Diabetes by OX40 Ligand
Martín‐Orozco, N., Chen, Z., Poirot, L., Hyatt, E., Chen, A., Kanagawa, O., Sharpe, A. H., Mathis, D. J., & Benoist, C. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6954 · Cited by 40
OX40 Controls Islet Allograft Tolerance in CD154 Deficient Mice by Regulating FOXP3+ Tregs
Chen, M., Xiao, X., Demirci, G., & Li, X. C. (2008) · Transplantation · doi:10.1097/tp.0b013e3181726987 · Cited by 39
Hong, G. U., Kim, N. G., Jeoung, D., & Ro, J. Y. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.002 · Cited by 38
Boettler, T., Choi, Y. S., Salek‐Ardakani, S., Cheng, Y., Moeckel, F., Croft, M., Crotty, S., & von Herrath, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300013 · Cited by 38
The T-Cell Immune Response against Kaposi's Sarcoma-Associated Herpesvirus
Robey, R. C., Mletzko, S., & Gotch, F. M. (2010) · Advances in Virology · doi:10.1155/2010/340356 · Cited by 37
CD134 as target for specific drug delivery to auto-aggressive CD4+T cells in adjuvant arthritis
Boot, E. P. J., Koning, G. A., Storm, G., Wagenaar-Hilbers, J. P. A., van Eden, W., Everse, L. A., & Wauben, M. H. M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1722 · Cited by 35
Mayer, C. T., Tian, L., Hesse, C., Kühl, A. A., Swallow, M., Kruse, F., Thiele, M., Gershwin, M. E., Liston, A., & Sparwasser, T. D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.08.010 · Cited by 29
Small‐molecule modulators of the OX 40– OX40 ligand co‐stimulatory protein–protein interaction
Song, Y. G., Margolles‐Clark, E., Bayer, A. L., & Buchwald, P. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12819 · Cited by 28
Anti-OX40 Prevents Effector T-Cell Accumulation and CD8+ T-Cell Mediated Skin Allograft Rejection
Kinnear, G., Wood, K. J., Marshall, D., & Jones, N. D. (2010) · Transplantation · doi:10.1097/tp.0b013e3181fe5396 · Cited by 28
Rajabi, P., Alaee, M., Mousavizadeh, K., & Samadikuchaksaraei, A. (2012) · Inflammation Research · doi:10.1007/s00011-012-0535-6 · Cited by 24
Characterization of the expanded T‐cell populations in patients with Wegener's granulomatosis
Giscombe, R., WANG, X. B., Kakoulidou, M., & Lefvert, A. K. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01688.x · Cited by 23
Tone, Y., Kojima, Y., Furuuchi, K., Brady, M., Yashiro–Ohtani, Y., Tykocinski, M. L., & Tone, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1760 · Cited by 23
Marriott, C. L., Mackley, E. C., Ferreira, C., Veldhoen, M., Yagita∥, H., & Withers, D. R. (2014) · European Journal of Immunology · doi:10.1002/eji.201344211 · Cited by 19
Zhou, Y., Rengao, Y., Li, Y.-J., Xie, C., & Wu, Y. (2008) · Autoimmunity · doi:10.1080/08916930802002240 · Cited by 19
Smeets, E., Meiler, S. U., & Lutgens, E. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000025 · Cited by 18
Wang, Y., Li, M., Song, M., Xu, X., Xiong, J., Xiao-ya, Y., Tan, J., & Bai, Y. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.04.002 · Cited by 18
Activation of OX40 Prolongs and Exacerbates Autoimmune Experimental Uveitis
Wu, X., Rosenbaum, J. T., Adamus, G., Zhang, G. L., Duan, J., Weinberg, A. D., & Zhang, Z. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7664 · Cited by 15
Łuczyński, W., Stasiak‐Barmuta, A., Juchniewicz, A., Wawrusiewicz‐Kurylonek, N., Iłendo, E., Kos, J., Kretowski, A. J., Górska, M., Chyczewski, L., & Bossowski, A. T. (2010) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0113-5 · Cited by 15
Elmann, A., Sharabi, A., Dayan, M., Zinger, H., Ophir, R., & Mozes, E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22736 · Cited by 14
Passacantando, A., Parzanese, I., Rascente, M., Petrucci, C., Minisola, G., & TONIETTI, G. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900305 · Cited by 14
Analysis of the cellular infiltrate in the iris during experimental autoimmune encephalomyelitis.
de Vos, A. F., Dick, A. D., Klooster, J., Broersma, L., McMenamin, P. G., & Kijlstra, A. (2000) · UWA Profiles and Research Repository (UWA) · Cited by 12
Júnior, D. M., Cruvinel, W. M., Araújo, J. A. P., Salmazi, K. C., Kallas, E. G., & Andrade, L. E. C. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143483 · Cited by 8
Evolving Strategies for Cancer and Autoimmunity: Back to the Future
Lane, P. J. L., McConnell, F. M., Anderson, G., Nawaf, M. G., Gaspal, F., & Withers, D. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00154 · Cited by 8
Self-citationActivation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200010)30:10 · Cited by 3
IL-15 controls T cell functions through its influence on CD30 and OX40 antigens in Celiac Disease
Períolo, N., Guillén, L., Arruvito, M. L., Alegre, N. S., Niveloni, S. I., Hwang, J. H., Bai, J., & Cherñavsky, A. C. (2014) · Cytokine · doi:10.1016/j.cyto.2014.01.004 · Cited by 3
Cited by
Molecular mimicry and autoimmunity
Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J.-M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.012 · Cited by 627
TH2 cell development and function
Walker, J. A., & McKenzie, A. N. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.118 · Cited by 632
Machado-Santos, J., Saji, E., Tröscher, A. R., Paunovic, M., Liblau, R., Gabriely, G., Bien, C. G., Bauer, J., & Lassmann, H. (2018) · Brain · doi:10.1093/brain/awy151 · Cited by 548
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
Fu, Y., Lin, Q., Zhang, Z., & Zhang, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.010 · Cited by 260
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Metadata
- Authors
- Webb, G. J., Hirschfield, G. M., & Lane, P. J. L.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2015-07-28
- Volume
- 50
- Issue
- 3
- Pages
- 312-332
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W980174965
- Cited by
- 277
- References
- 135
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.